Glial cell line-derived neurotrophic factor (GDNF) is one of the candidate molecules among neurotrophic factors proposed for a potential treatment of retinitis pigmentosa (RP). It must be administered repeatedly or through sustained releasing systems to exert prolonged neuroprotective effects. In the dystrophic Royal College of Surgeon's (RCS) rat model of RP, we found that endogenous GDNF levels dropped during retinal degeneration time course, opening a therapeutic window for GDNF supplementation. We showed that after a single electrotransfer of 30 μg of GDNF-encoding plasmid in the rat ciliary muscle, GDNF was produced for at least 7 months. Morphometric, electroretinographic and optokinetic analyses highlighted that this continuous release of GDNF delayed photoreceptors (PRs) as well as retinal functions loss until at least 70 days of age in RCS rats. Unexpectedly, increasing the GDNF secretion level accelerated PR degeneration and the loss of electrophysiological responses. This is the first report: (i) demonstrating the efficacy of GDNF delivery through non-viral gene therapy in RP; (ii) establishing the efficacy of intravitreal administration of GDNF in RP associated with a mutation in the retinal pigment epithelium; and (iii) warning against potential toxic effects of GDNF within the eye/retina.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Journal of Translational Medicine Open Access 07 December 2022
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Cottet S, Schorderet DF . Mechanisms of apoptosis in retinitis pigmentosa. Curr Mol Med 2009; 9: 375–383.
Bainbridge JW, Tan MH, Ali RR . Gene therapy progress and prospects: the eye. Gene Therapy 2006; 13: 1191–1197.
Cideciyan AV, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, Boye SL et al. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther 2009; 20: 999–1004.
Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL et al. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 2010; 18: 643–650.
Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM . Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990; 347: 83–86.
LaVail MM, Yasumura D, Matthes MT, Lau-Villacorta C, Unoki K, Sung CH et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998; 39: 592–602.
Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 2006; 103: 3896–3901.
Frasson M, Picaud S, Leveillard T, Simonutti M, Mohand-Said S, Dreyfus H et al. Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci 1999; 40: 2724–2734.
Cayouette M, Smith SB, Becerra SP, Gravel C . Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis 1999; 6: 523–532.
Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz AC, Clerin E et al. Identification and characterization of rod-derived cone viability factor. Nat Genet 2004; 36: 755–759.
Buch PK, MacLaren RE, Duran Y, Balaggan KS, MacNeil A, Schlichtenbrede FC et al. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration. Mol Ther 2006; 14: 700–709.
Gerwins P, Skoldenberg E, Claesson-Welsh L . Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 2000; 34: 185–194.
Rousseau B, Dubayle D, Sennlaub F, Jeanny JC, Costet P, Bikfalvi A et al. Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells. Exp Eye Res 2000; 71: 395–404.
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F . GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130–1132.
Lin LF, Zhang TJ, Collins F, Armes LG . Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J Neurochem 1994; 63: 758–768.
Airaksinen MS, Saarma M . The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002; 3: 383–394.
Jomary C, Thomas M, Grist J, Milbrandt J, Neal MJ, Jones SE . Expression patterns of neurturin and its receptor components in developing and degenerative mouse retina. Invest Ophthalmol Vis Sci 1999; 40: 568–574.
Nosrat CA, Tomac A, Lindqvist E, Lindskog S, Humpel C, Stromberg I et al. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res 1996; 286: 191–207.
Lindqvist N, Peinado-Ramonn P, Vidal-Sanz M, Hallbook F . GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection. Exp Neurol 2004; 187: 487–499.
Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S et al. Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 2002; 22: 9228–9236.
Jomary C, Darrow RM, Wong P, Organisciak DT, Jones SE . Expression of neurturin, glial cell line-derived neurotrophic factor, and their receptor components in light-induced retinal degeneration. Invest Ophthalmol Vis Sci 2004; 45: 1240–1246.
Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996; 85: 1113–1124.
Ogilvie JM, Speck JD, Lett JM . Growth factors in combination, but not individually, rescue rd mouse photoreceptors in organ culture. Exp Neurol 2000; 161: 676–685.
Politi LE, Rotstein NP, Carri NG . Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2001; 42: 3008–3015.
Carwile ME, Culbert RB, Sturdivant RL, Kraft TW . Rod outer segment maintenance is enhanced in the presence of bFGF, CNTF and GDNF. Exp Eye Res 1998; 66: 791–805.
Klocker N, Braunling F, Isenmann S, Bahr M . In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells. Neuroreport 1997; 8: 3439–3442.
Andrieu-Soler C, Aubert-Pouessel A, Doat M, Picaud S, Halhal M, Simonutti M et al. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis 2005; 11: 1002–1011.
Gregory-Evans K, Chang F, Hodges MD, Gregory-Evans CY . Ex vivo gene therapy using intravitreal injection of GDNF-secreting mouse embryonic stem cells in a rat model of retinal degeneration. Mol Vis 2009; 15: 962–973.
D’Cruz PM, Yasumura D, Weir J, Matthes MT, Abderrahim H, LaVail MM et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 2000; 9: 645–651.
Nandrot E, Dufour EM, Provost AC, Pequignot MO, Bonnel S, Gogat K et al. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiol Dis 2000; 7: 586–599.
Gal A, Li Y, Thompson DA, Weir J, Orth U, Jacobson SG et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 2000; 26: 270–271.
Dowling JE, Sidman RL . Inherited retinal dystrophy in the rat. J Cell Biol 1962; 14: 73–109.
Herron WL, Riegel BW, Myers OE, Rubin ML . Retinal dystrophy in the rat—a pigment epithelial disease. Invest Ophthalmol 1969; 8: 595–604.
Tso MO, Zhang C, Abler AS, Chang CJ, Wong F, Chang GQ et al. Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats. Invest Ophthalmol Vis Sci 1994; 35: 2693–2699.
Bush RA, Hawks KW, Sieving PA . Preservation of inner retinal responses in the aged Royal College of Surgeons rat. Evidence against glutamate excitotoxicity in photoreceptor degeneration. Invest Ophthalmol Vis Sci 1995; 36: 2054–2062.
LaVail MM, Sidman M, Rausin R, Sidman RL . Discrimination of light intensity by rats with inherited retinal degeneration: a behavioral and cytological study. Vision Res 1974; 14: 693–702.
Ejstrup R, Kiilgaard JF, Tucker BA, Klassen HJ, Young MJ, La Cour M . Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs. Exp Eye Res 2010; 91: 890–895.
Gamm DM, Wang S, Lu B, Girman S, Holmes T, Bischoff N et al. Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One 2007; 2: e338.
Lawrence JM, Keegan DJ, Muir EM, Coffey PJ, Rogers JH, Wilby MJ et al. Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 2004; 45: 267–274.
McGee Sanftner LH, Abel H, Hauswirth WW, Flannery JG . Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 2001; 4: 622–629.
Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D et al. Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. FASEB J 2006; 20: 389–391.
Touchard E, Kowalczuk L, Bloquel C, Naud MC, Bigey P, Behar-Cohen F . The ciliary smooth muscle electrotransfer: basic principles and potential for sustained intraocular production of therapeutic proteins. J Gene Med 2010; 12: 904–919.
Kowalczuk L, Touchard E, Camelo S, Naud MC, Castaneda B, Brunel N et al. Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle. Invest Ophthalmol Vis Sci 2009; 50: 1761–1768.
Touchard E, Bloquel C, Bigey P, Kowalczuc L, Jonet L, Thillaye-Goldenberg B et al. Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis. Gene Therapy 2009; 16: 862–873.
Delyfer MN, Simonutti M, Neveux N, Leveillard T, Sahel JA . Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST? Mol Vis 2005; 11: 677–687.
Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM . Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci 1992; 12: 3554–3567.
Silverman MS, Hughes SE . Photoreceptor rescue in the RCS rat without pigment epithelium transplantation. Curr Eye Res 1990; 9: 183–191.
Qi H, Chuang EY, Yoon KC, de Paiva CS, Shine HD, Jones DB et al. Patterned expression of neurotrophic factors and receptors in human limbal and corneal regions. Mol Vis 2007; 13: 1934–1941.
Qi H, Zheng X, Yuan X, Pflugfelder SC, Li DQ . Potential localization of putative stem/progenitor cells in human bulbar conjunctival epithelium. J Cell Physiol 2010; 225: 180–185.
Morimoto T, Fujikado T, Choi JS, Kanda H, Miyoshi T, Fukuda Y et al. Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats. Invest Ophthalmol Vis Sci 2007; 48: 4725–4732.
Pardue MT, Phillips MJ, Yin H, Fernandes A, Cheng Y, Chow AY et al. Possible sources of neuroprotection following subretinal silicon chip implantation in RCS rats. J Neural Eng 2005; 2: S39–S47.
Pardue MT, Phillips MJ, Yin H, Sippy BD, Webb-Wood S, Chow AY et al. Neuroprotective effect of subretinal implants in the RCS rat. Invest Ophthalmol Vis Sci 2005; 46: 674–682.
DeMarco Jr PJ, Yarbrough GL, Yee CW, McLean GY, Sagdullaev BT, Ball SL et al. Stimulation via a subretinally placed prosthetic elicits central activity and induces a trophic effect on visual responses. Invest Ophthalmol Vis Sci 2007; 48: 916–926.
Read SP, Cashman SM, Kumar-Singh R . POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse. Mol Ther 2010; 18: 1917–1926.
Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD et al. Characterization of a multicomponent receptor for GDNF. Nature 1996; 382: 80–83.
Takahashi M, Cooper GM . ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 1987; 7: 1378–1385.
Sanicola M, Hession C, Worley D, Carmillo P, Ehrenfels C, Walus L et al. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci USA 1997; 94: 6238–6243.
Trupp M, Scott R, Whittemore SR, Ibanez CF . Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem 1999; 274: 20885–20894.
Harada C, Harada T, Quah HM, Maekawa F, Yoshida K, Ohno S et al. Potential role of glial cell line-derived neurotrophic factor receptors in Muller glial cells during light-induced retinal degeneration. Neuroscience 2003; 122: 229–235.
Koeberle PD, Ball AK . Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor. Neuroscience 2002; 110: 555–567.
Hauck SM, Kinkl N, Deeg CA, Swiatek-de Lange M, Schoffmann S, Ueffing M . GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol Cell Biol 2006; 26: 2746–2757.
Delyfer MN, Forster V, Neveux N, Picaud S, Leveillard T, Sahel JA . Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina. Mol Vis 2005; 11: 688–696.
Koeberle PD, Bahr M . The upregulation of GLAST-1 is an indirect antiapoptotic mechanism of GDNF and neurturin in the adult CNS. Cell Death Differ 2008; 15: 471–483.
Shoji F, Yamasoba T, Magal E, Dolan DF, Altschuler RA, Miller JM . Glial cell line-derived neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear Res 2000; 142: 41–55.
Hovland Jr DN, Boyd RB, Butt MT, Engelhardt JA, Moxness MS, Ma MH et al. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol Pathol 2007; 35: 1013–1029.
Hutchinson M . On the toxicity of GDNF. Toxicol Pathol 2008; 36: 522.
Wu WC, Lai CC, Chen SL, Sun MH, Xiao X, Chen TL et al. Long-term safety of GDNF gene delivery in the retina. Curr Eye Res 2005; 30: 715–722.
Yan Q, Wang J, Matheson CR, Urich JL . Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF). J Neurobiol 1999; 38: 382–390.
Sajadi A, Bauer M, Thony B, Aebischer P . Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production. J Neurochem 2005; 93: 1482–1486.
Brandies R, Yehuda S . The possible role of retinal dopaminergic system in visual performance. Neurosci Biobehav Rev 2008; 32: 611–656.
Khoury M, Bigey P, Louis-Plence P, Noel D, Rhinn H, Scherman D et al. A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J Gene Med 2006; 8: 1027–1036.
Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM . ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996; 62: 155–169.
Kingston RE, Chen CA, Rose JK . Calcium phosphate transfection. Curr Protoc Mol Biol 2003; Chap 9: Unit 9 1.
Schenborn ET, Goiffon V . Calcium phosphate transfection of mammalian cultured cells. Methods Mol Biol 2000; 130: 135–145.
Prusky GT, Alam NM, Beekman S, Douglas RM . Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci 2004; 45: 4611–4616.
Koeberle PD, Ball AK . Effects of GDNF on retinal ganglion cell survival following axotomy. Vision Res 1998; 38: 1505–1515.
Kilic U, Kilic E, Dietz GP, Bahr M . The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection. Neurodegener Dis 2004; 1: 44–49.
Ward MS, Khoobehi A, Lavik EB, Langer R, Young MJ . Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J Pharm Sci 2007; 96: 558–568.
Jiang C, Moore MJ, Zhang X, Klassen H, Langer R, Young M . Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Mol Vis 2007; 13: 1783–1792.
Kyhn MV, Klassen H, Johansson UE, Warfvinge K, Lavik E, Kiilgaard JF et al. Delayed administration of glial cell line-derived neurotrophic factor (GDNF) protects retinal ganglion cells in a pig model of acute retinal ischemia. Exp Eye Res 2009; 89: 1012–1020.
Schmeer C, Straten G, Kugler S, Gravel C, Bahr M, Isenmann S . Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of glial cell-line derived neurotrophic factor in vivo. Eur J Neurosci 2002; 15: 637–643.
Straten G, Schmeer C, Kretz A, Gerhardt E, Kugler S, Schulz JB et al. Potential synergistic protection of retinal ganglion cells from axotomy-induced apoptosis by adenoviral administration of glial cell line-derived neurotrophic factor and X-chromosome-linked inhibitor of apoptosis. Neurobiol Dis 2002; 11: 123–133.
Wu WC, Lai CC, Chen SL, Sun MH, Xiao X, Chen TL et al. GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol Vis 2004; 10: 93–102.
Wu WC, Lai CC, Chen SL, Xiao X, Chen TL, Tsai RJ et al. Gene therapy for detached retina by adeno-associated virus vector expressing glial cell line-derived neurotrophic factor. Invest Ophthalmol Vis Sci 2002; 43: 3480–3488.
Allocca M, Di Vicino U, Petrillo M, Carlomagno F, Domenici L, Auricchio A . Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage. Invest Ophthalmol Vis Sci 2007; 48: 5199–5206.
Ishikawa H, Takano M, Matsumoto N, Sawada H, Ide C, Mimura O et al. Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Therapy 2005; 12: 289–298.
Dong A, Shen J, Krause M, Hackett SF, Campochiaro PA . Increased expression of glial cell line-derived neurotrophic factor protects against oxidative damage-induced retinal degeneration. J Neurochem 2007; 103: 1041–1052.
This work was funded in part by the ANR EMERGENCE project ANR-05-EMPB-001-02 and the European project EVI-GENORET LSHG-CT-2005-512036.
The authors declare no conflict of interest.
About this article
Cite this article
Touchard, E., Heiduschka, P., Berdugo, M. et al. Non-viral gene therapy for GDNF production in RCS rat: the crucial role of the plasmid dose. Gene Ther 19, 886–898 (2012). https://doi.org/10.1038/gt.2011.154
This article is cited by
Journal of Translational Medicine (2022)
Repair of Rhodopsin mRNA by Spliceosome-Mediated RNA Trans -Splicing: A New Approach for Autosomal Dominant Retinitis Pigmentosa
Molecular Therapy (2015)
Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization
Gene Therapy (2013)
GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophins
Graefe's Archive for Clinical and Experimental Ophthalmology (2012)